Chromosome Microarray (CMA) Detection - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.

2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.

PREV: Chromosome Microarray (CMA) Detection (3)

NEXT: Chromosome Microarray (CMA&STR) Detection 2.0

Related IVD Products

Related News Of IVD Technology

Fighting Infectious Diseases: Microarray Hybridization Stations in Pathogen DetectionJanuary 4, 2024In recent years, the rapid spread of infectious diseases has become a global concern. Detecting and identifying pathogens with accuracy and speed is crucial for effective disease surveillance and cont...view
Caution! Streptococcus Pneumoniae Disease Has Become the Second Leading Cause of Death Among Children Under 5August 31, 2023Pneumonia affects people's health globally and is a common respiratory system infectious disease. It is also a significant cause of death in children worldwide due to infection. Streptococcus pneu...view
Unveiling the Microbial World: The Power of Whole Genome Shotgun MetagenomicsJune 5, 2024Whole genome shotgun metagenomics is a revolutionary technique that allows scientists to sequence the genomes of entire microbial communities without the need for culturing them first. This groundbrea...view
Genomic Photography: Capturing Genetic Landscapes with Microarray ScannersJanuary 4, 2024In the world of genetics, capturing and comprehending the complex genomic landscapes has always been a challenge. However, with the advent of microarray scanners, researchers and scientists are now ab...view
Navigating the Landscape of Different NGS Platforms: A Comprehensive GuideJune 5, 2024he development of next-generation sequencing (NGS) over the past 15 to 20 years has seen multiple technologies rapidly leapfrogging each other’s milestones to sequence more DNA faster, cheaper, and m...view
Decoding Genomic Medicine: The Power of Clinical WES in Patient CareJanuary 4, 2024In recent years, genomic medicine has revolutionized the way healthcare professionals diagnose and treat various diseases. A key component of this approach is Clinical WES (Whole Exome Sequencing), wh...view